Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
36.81
-0.61 (-1.63%)
Feb 21, 2025, 4:00 PM EST - Market closed
Kymera Therapeutics Employees
Kymera Therapeutics had 187 employees as of December 31, 2023. The number of employees increased by 20 or 11.98% compared to the previous year.
Employees
187
Change (1Y)
20
Growth (1Y)
11.98%
Revenue / Employee
$468,251
Profits / Employee
-$895,583
Market Cap
2.38B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 187 | 20 | 11.98% |
| Dec 31, 2022 | 167 | 26 | 18.44% |
| Dec 31, 2021 | 141 | 66 | 88.00% |
| Dec 31, 2020 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
KYMR News
- 23 days ago - Kymera Therapeutics to Participate in Upcoming February Investor Conferences - GlobeNewsWire
- 5 weeks ago - Kymera Therapeutics Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs - GlobeNewsWire
- 6 weeks ago - Kymera Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14 - GlobeNewsWire
- 2 months ago - Kymera: Protein Degradation Could Drive Dupixent-Like Value - Seeking Alpha
- 3 months ago - Kymera Therapeutics to Participate in Upcoming December Investor Conferences - GlobeNewsWire
- 3 months ago - Kymera Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 3 months ago - Kymera Therapeutics, Inc. (KYMR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire